When:
Time: 7:00am PDT, 10:00am EDT, 3:00pm BST, 4:00pm CEST
Duration: 150 minutes
Join us on our final day of talks to discover how Novo Nordisk, KP and IntrinsiQ are using NLP with topics such as:
- Text-mining journey with Linguamatics - a collaboration story
- Using NLP to find Adverse Events and create cases during safety case processing
- Value from bench to bedside: Developments and key application areas for NLP in pharma
Agenda
10:00 am Greg Carmichael (Linguamatics) - Introduction
10:10 am Solmaz Gabery Adams (Novo Nordisk) - TBC
10:30 am Jane Reed (Linguamatics) - NLP for decision support: bench to bedside
11:05 am Updesh Dosanjh (IQVIA) - Using NLP to find Adverse Events and create cases during safety case processing
11:30 am TBC
11:50 am Panel Discussion
12:10 pm Greg Carmichael (Linguamatics) - Wrap Up
Speakers
Solmaz Gabery Adams
Senior Information Scientist, Novo NordiskSolmaz Gabery Adams
Solmaz has a background in Bioinformatics from the Technical University of Denmark and has been working with text-mining solutions for the past 10+ years in Novo Nordisk Global Information & Analysis (GLIA). GLIA supports the Novo Nordisk organisation with external information and information consultancy services such as text-mining, visualisations and intelligence newsletters. Whilst driving the text-mining strategy Solmaz is responsible for the overall solutions architecture and integrations. She ensures the team of information consultants are working with the best solutions, seamlessly integrated into the IT infrastructure, securing a foundation on which they can excel.
Jane Reed
Director of Life Sciences, LinguamaticsJane Reed
Dr. Jane Reed is Director, Life Sciences, at Linguamatics, an IQVIA company. Jane is responsible for developing the strategic vision for Linguamatics’ growing product portfolio and business development in the life science domain. Jane has extensive experience in life sciences informatics. She has worked for more than 15 years in vendor companies supplying data products, data integration and analysis and consultancy to pharma and biotech - with roles at Instem, BioWisdom, Incyte, and Hexagen.
Updesh Dosanjh
Practice Leader, Safety Technology Solutions, IQVIAUpdesh Dosanjh
As Practice Leader for the Technology Solutions business unit of IQVIA, Updesh Dosanjh is responsible developing the overarching strategy regarding Artificial Intelligence and Machine Learning as it relates to safety and pharmacovigilance. He is focused on the adoption of these innovative technologies and processes that will help optimize pharmacovigilance activities for better, faster results. Dosanjh has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition
